AzTrials
AzTrials

Out-of-hospital Cardiac ArrestPhase 3RINSENCT01173393

Rapid Infusion of Cold Normal Saline During CPR for Patients With Out-of-hospital Cardiac Arrest

A Phase 3 study testing PARAMEDIC COOLING in people with Out-of-hospital Cardiac Arrest, run by Ambulance Victoria at 1 site in Australia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

That paramedic core cooling during CPR using a rapid infusion of ice-cold (4 degrees C) large-volume (30mL/kg) normal saline improves outcome at hospital discharge compared with standard care in patients with out-of-hospital cardiac arrest. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Out-of-hospital Cardiac Arrest
What is being tested?
PARAMEDIC COOLING
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,220 participants
Where
1 siteAustralia
Study dates
Jul 2010to Dec 2014
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • In cardiac arrest following trauma or suspected intra-cranial bleeding/ obviously pregnant/ Dependant on others for activities of daily living (ie any assistance with activities of daily living, in supported care or nursing home residents) or have pre-existing significant neurological injury,Likely to be "Not for Resuscitation" and/or admission to the Intensive Care Unit because of terminal disease or advanced age, Patients who are hypothermic already and are confirmed to be on temperature measurement/ in-hospital cardiac arrest.

Trial locations and contacts

1 site in 1 country.

Australia1 site
  • Ambulance Victoria

    Melbourne

Other trials in Australia

About this study

Official title: The RINSE Trial: Rapid Infusion of Cold Saline During CPR for Patients With Cardiac Arrest

That paramedic core cooling during CPR using a rapid infusion of ice-cold (4 degrees C) large-volume (30mL/kg) normal saline improves outcome at hospital discharge compared with standard care in patients with out-of-hospital cardiac arrest.

Read the detailed description

INTRODUCTION:

Pre-hospital cardiac arrest is common and associated with a poor prognosis and only about 8% of patients have a good outcome. For patients who are initially successfully resuscitated by ambulance paramedics and transported to hospital, there is considerable mortality and morbidity. This is largely due to the anoxic brain injury sustained during the cardiac arrest.

One current therapy for the severe anoxic brain injury following out-of-hospital cardiac arrest is therapeutic hypothermia (TH) induced after resuscitation. This treatment was shown to improve outcomes in two clinical trials. The International Liaison Committee on Resuscitation now recommend TH (33°C for 12-24 hours) for patients who remain comatose after resuscitation from cardiac arrest.

However, the optimal timing of TH is still uncertain. The above clinical studies used surface cooling and this delayed TH until after arrival at the hospital. On the other hand, laboratory data has suggested that there is significantly decreased neurological injury if cooling is initiated during CPR.

The current ideal technique for induction of TH during CPR is a rapid intravenous infusion of a large volume of ice-cold fluid. This technique has become established as the cooling method of choice in the pre-hospital setting, the Emergency Department (14) and the Intensive Care Unit.

Previously, we conducted a randomised, controlled trial of paramedic cooling after CPR compared with cooling in the emergency department (ED) (NHMRC study number 236879). This study enrolled 396 patients between 2005 and late 2007. There were 234 patients with an initial cardiac rhythm of ventricular fibrillation (VF) and 163 patients with an initial cardiac rhythm of non-VF (asystole or pulseless electrical activity).

In the post-VF arrest patients, there was a good outcome (discharge to home or to rehabilitation) in both groups of 50%. In the post-non-VF arrest patients, there was a good outcome at hospital discharge of 12% in the paramedic cooled group compared with 9% in the standard care group. The study was stopped at the interim analysis due to a lack of difference in the primary outcome measure (outcome at hospital discharge) between the two groups (futility).

Further analysis of this data revealed that paramedics infused up to 1000mL ambient temperature fluid during CPR prior to enrolment as part of standard paramedic treatment. In addition, the rapid infusion of cold fluid was commenced en-route to hospital. Thus, cooling commenced approximately 30 minutes after paramedic arrival and only just prior to hospital cooling. Although there was a decrease in the core temperatures of the patients allocated to pre-hospital cooling on arrival at the ED, this was a transient effect lasting only approximately 20 minutes. Subsequently, the cooling curves of the patients in both groups were identical. Thus, it was considered unlikely that this transient difference in core temperature could have a measurable effect on outcomes.

Laboratory data suggests that a rapid intravenous infusion of cold fluid during CPR effectively decreases core temperature. Nordmark et al. studied the induction of hypothermia with a large volume of intravenous ice-cold fluid after cardiac arrest during CPR in anaesthetised piglets who were subjected to eight minutes of VF. The mean temperature reduction was 1.6°C in the hypothermic group and 1.1°C in the control group (p=0.009).

There is also laboratory data that cooling during CPR may increase the rate of successful defibrillation. Boddicker et al. examined the success rates of defibrillation in swine cooled to different temperatures. After 8 minutes of VF (with no CPR), the animals were defibrillated with successive shocks as needed and underwent CPR until resumption of spontaneous circulation or no response. First-shock defibrillation success was highest in the hypothermia (33°C) group (6/8 hypothermia versus 1/8 normothermia; P=0.04). None of the 8 animals in the normothermia group achieved resumption of spontaneous circulation compared with 7/8 moderate hypothermia (P=0.001). Coronary perfusion pressure during CPR was not different between the groups, thus this beneficial effect of hypothermia was not due to alteration of coronary perfusion pressure but likely due to changes in the electrophysiological properties of the myocardium. Thus, it appears that mild hypothermia may have a beneficial anti-arrhythmic effect, as well as a neuroprotective effect.

More recently, pilot clinical trials have been undertaken in Europe that suggest that cooling during CPR by paramedics is feasible. For example, Bruel et al studied the feasibility and safety of a rapid infusion of 2000mL of normal saline at 4°C during CPR. A total of 33 patients were included in the study of whom eight patients presented with VF as the initial cardiac rhythm. After intravenous cooling, the temperature in the patients decreased by a mean of 2.1°C.

In a similar pilot study, Kämäräinen et al. cooled seventeen adult patients with out-of-hospital cardiac arrest during CPR. A return of circulation was achieved in 13 patients (76%). The temperature of the patients on hospital admission was a mean of 33.8°C and the mean infused volume of cold fluid was 1571mL. The authors concluded that induction of therapeutic hypothermia during prehospital CPR was feasible and apparently well tolerated.

More recent data specifically examining respiratory function in 52 patients treated with large volume, ice cold saline has indicated that there is no adverse effect on respiratory function.

Given this supportive laboratory and preliminary clinical data, and our previous experience in running a large pre-hospital trial in cardiac arrest patients, we propose to conduct a definitive randomized, controlled trial of paramedic cooling during CPR compared with standard care including cooling after arrival at the hospital.

In the treatment arm, paramedics will undertake immediate cooling during cardiac arrest, using a large volume (20mL/kg, followed by 10mL/kg) intravenous bolus of ice-cold saline. This strategy will overcome the delay in treatment that was found in our previous study. Thus, cooling will commence significantly earlier, possibly resulting in significantly improved rates of resuscitation and better neurological outcomes.

In the control arm, patients will be resuscitated using current protocols and be cooled after arrival at the hospital (the current standard of care).

The trial will run as two parallel clinical trials because of the marked difference in outcomes between patients with VF as the initial cardiac rhythm and patients with non-VF as the initial cardiac rhythm.

STUDY DETAILS

HYPOTHESIS:

That paramedic core cooling during CPR using a rapid infusion of ice-cold (4 degrees C) large volume (30mL/kg total) normal saline improves outcome at hospital discharge compared with standard care in patients with out-of-hospital cardiac arrest.

Being tested
PARAMEDIC COOLING
Keywords
out of hospital cardiac arrest, OHCA, EMS, Emergency medical System, non-VF, non-ventricular fibrillation
Medical subject headings
Out-of-Hospital Cardiac Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PARAMEDIC COOLINGProcedure or surgery

    Also called Intervention arm

    For patients randomised to paramedic cooling:

    • LMA/ Intubation and ventilation with 100% oxygen
    • Measure temperature using tympanic probe and record
    • Paramedic cooling using infusion of 20mL/kg cold fluid via IV during CPR
    • If temperature >34.5ºC, infuse further 10mL/kg stat
    • After ROSC, infuse further (max 2 litres) ice-cold saline
    • If shivering occurs post resuscitation and intubated, administer midazolam 2-5mg IV and pancuronium 8 mg.
Study groups in NCT01173393
Study groupRoleWhat they receive
Standard TreatmentNo interventionFor patients randomised to hospital cooling: * LMA/ Intubation and ventilation with 100% oxygen * Measure temperature using tympanic probe and record * Insert IV line and administer drugs as per protocol * Fluid challenge with standard temperature saline only as per current guideline (suspected hypovolemia) * Post resuscitation: midazolam 1-5 mg only to maintain LMA/ intubation as needed. * Pancuronium 8 mg only if intubation unable to be maintained with midazolam. After arrival at the Emergency Department, all patients receive standard care.
Receives: Procedure: PARAMEDIC COOLING

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Survival at hospital discharge

    Measured: At hospital discharge or 28 days

Secondary outcomes (2)
  1. Quality of Life

    Measured: 6 months

  2. Return of Spontaneous Circulation

    Measured: within 60 minutes of arrest

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2010 (estimated)
  2. Study startJul 2010
  3. Primary completionDec 2014
  4. Study completionDec 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Who is masked
Participant
Enrolment
1,220 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01173393
Sponsor's protocol ID
435/09 B
Acronym
RINSE
Status last verified
Jan 2015
First submitted
26 Jul 2010
Last updated
22 Jan 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Bernard SA, Rosalion A. Therapeutic hypothermia induced during cardiopulmonary resuscitation using large-volume, ice-cold intravenous fluid. Resuscitation. 2008 Feb;76(2):311-3. doi: 10.1016/j.resuscitation.2007.07.017. Epub 2007 Aug 31.

    PubMed 17765383
  • Bernard SA, Smith K, Cameron P, Masci K, Taylor DM, Cooper DJ, Kelly AM, Silvester W; Rapid Infusion of Cold Hartmanns Investigators. Induction of prehospital therapeutic hypothermia after resuscitation from nonventricular fibrillation cardiac arrest*. Crit Care Med. 2012 Mar;40(3):747-53. doi: 10.1097/CCM.0b013e3182377038.

    PubMed 22020244
  • Bernard SA, Smith K, Cameron P, Masci K, Taylor DM, Cooper DJ, Kelly AM, Silvester W; Rapid Infusion of Cold Hartmanns (RICH) Investigators. Induction of therapeutic hypothermia by paramedics after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest: a randomized controlled trial. Circulation. 2010 Aug 17;122(7):737-42. doi: 10.1161/CIRCULATIONAHA.109.906859. Epub 2010 Aug 2.

    PubMed 20679551
  • Bernard SA, Smith K, Finn J, Hein C, Grantham H, Bray JE, Deasy C, Stephenson M, Williams TA, Straney LD, Brink D, Larsen R, Cotton C, Cameron P. Induction of Therapeutic Hypothermia During Out-of-Hospital Cardiac Arrest Using a Rapid Infusion of Cold Saline: The RINSE Trial (Rapid Infusion of Cold Normal Saline). Circulation. 2016 Sep 13;134(11):797-805. doi: 10.1161/CIRCULATIONAHA.116.021989. Epub 2016 Aug 25.

    PubMed 27562972
  • Deasy C, Bernard S, Cameron P, Jacobs I, Smith K, Hein C, Grantham H, Finn J; RINSE investigators. Design of the RINSE trial: the rapid infusion of cold normal saline by paramedics during CPR. BMC Emerg Med. 2011 Oct 13;11:17. doi: 10.1186/1471-227X-11-17.

    PubMed 21995804

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing PARAMEDIC COOLING in people with Out-of-hospital Cardiac Arrest, run by Ambulance Victoria at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Survival at hospital discharge (time frame: At hospital discharge or 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01173393, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in